Eisler Capital Management Ltd. Takes Position in Surgery Partners, Inc. $SGRY

Key Points

• Eisler Capital Management Ltd. has acquired 51,977 shares of Surgery Partners, Inc. (NASDAQ: SGRY), valued at approximately $1.24 million, during the first quarter of the year.
• Several hedge funds, including Janus Henderson Group and Point72 Asset Management, significantly increased their stakes in Surgery Partners, indicating growing interest in the company.
• Analysts have assigned a "Moderate Buy" rating for Surgery Partners with an average target price of $33.00, despite Barclays reducing their target price from $25.00 to $24.00.

Eisler Capital Management Ltd. acquired a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 51,977 shares of the company's stock, valued at approximately $1,241,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. boosted its holdings in Surgery Partners by 12.1% in the fourth quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,296 shares of the company's stock valued at $91,000 after purchasing an additional 465 shares during the period. PNC Financial Services Group Inc. increased its position in shares of Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company's stock worth $28,000 after purchasing an additional 542 shares in the last quarter. AlphaQuest LLC increased its position in Surgery Partners by 112.0% in the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company's stock valued at $25,000 after acquiring an additional 559 shares during the period. Mackenzie Financial Corp increased its position in Surgery Partners by 2.8% in the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock valued at $465,000 after acquiring an additional 599 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Surgery Partners by 0.3% in the 1st quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company's stock valued at $8,115,000 after acquiring an additional 926 shares during the period.

Analysts Set New Price Targets

Several equities analysts have issued reports on SGRY shares. Barclays dropped their target price on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 27th. Bank of America assumed coverage on shares of Surgery Partners in a research note on Monday, July 28th. They issued a "buy" rating and a $28.00 target price for the company. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of the firm's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares in the company, valued at $1,027,234.02. This trade represents a 30.71% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.70% of the stock is owned by corporate insiders.

Surgery Partners Stock Down 0.1%

NASDAQ:SGRY traded down $0.03 during mid-day trading on Friday, hitting $22.69. The company had a trading volume of 1,129,767 shares, compared to its average volume of 1,676,963. The business has a fifty day simple moving average of $22.36 and a 200-day simple moving average of $22.79. The company has a current ratio of 1.93, a quick ratio of 1.78 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 1 year low of $18.87 and a 1 year high of $33.90. The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of -15.87 and a beta of 1.82.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. The company had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The firm's revenue was up 8.4% compared to the same quarter last year. During the same period last year, the company posted $0.21 earnings per share. Equities analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.